Stomach CancerNCT07540169
The Effect of Stress Ball on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer
A study testing A device/tool called a stress ball in people with Stomach Cancer and Chemotherapy-induced Nausea and Vomiting, run by Yuzuncu Yil University at 2 sites in Turkey (Türkiye).
Trial summary
In this study, we will observe the effects of the Stress Ball. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Stomach Cancer, Chemotherapy-induced Nausea and Vomiting, Fatigue
- What is being tested?
- A device/tool called a stress ball
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 52 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 20 Mar 2026to 6 Jul 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Between the ages of 18-80
- Those who agree to participate in the study
- Those without motor skill loss
- Patients diagnosed with stomach cancer
- Patients with hand-arm orientation skills
Who cannot join
- Patients with loss of motor skills
- Patients who wish to withdraw from the study
Trial locations and contacts
2 sites in 1 country.
Turkey (Türkiye)2 sites
Institute of Health Sciences
Van, Tuşba, 65030
Van Yüzüncü Yıl University Institute of Health Sciences
Van, Tuşba, 65030
About this study
Official title: The Effect of Stress Balls on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer
In this study, we will observe the effects of the Stress Ball.
Read the detailed description
In this study and its process, we are investigating the effects of a stress ball on anxiety, nausea, and fatigue in patients undergoing chemotherapy and diagnosed with stomach cancer.
- Being tested
- A device/tool called a stress ball
- Keywords
- Stress Ball
- Medical subject headings
- Stomach Neoplasms, Vomiting, Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
A device/tool called a stress ballDevice
We are investigating what effects stress balls have on the aforementioned areas/personal experiences.
| Study group | Role | What they receive |
|---|---|---|
| Experimental Group | Experimental | Participants who were given a stress ball Receives: Device: A device/tool called a stress ball |
| Control Group | No intervention | Only the group being observed. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Anxiety
Anxiety will be measured during chemotherapy.
Measured: up to 6 months
Secondary outcomes (1)
Nausea and fatigue
Nausea and fatigue will be measured during chemotherapy.
Measured: up to 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Apr 2026
- Study start20 Mar 2026
- Primary completion6 Jul 2026
- Study completion6 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stomach CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The study consisted of experimental and control groups, both sexes, of patients diagnosed with gastric cancer.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 52 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yuzuncu Yil University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yavuz Uren, Yuzuncu Yil University
- Investigators
- Yavuz Uren, Study director, Van Yüzüncü Yıl University Institute of Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07540169
- Sponsor's protocol ID
- Stomach Cancer - Stress Balls
- Status last verified
- Jul 2026
- First submitted
- 14 Mar 2026
- Last updated
- 7 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Stress Balls on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer
- ClinicalTrials.gov ID
- NCT07540169
- Acronym / sponsor ID
- Stomach Cancer - Stress Balls
- Keywords
- Stress Ball
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 52 participants (actual)
- Lead sponsor
- Yuzuncu Yil UniversityUniversity, hospital or other
- Study start
- 20 Mar 2026 (actual)
- Primary completion
- 6 Jul 2026 (actual)
- Study completion
- 6 Jul 2026 (actual)
- First posted
- 20 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, we will observe the effects of the Stress Ball.
Detailed description
In this study and its process, we are investigating the effects of a stress ball on anxiety, nausea, and fatigue in patients undergoing chemotherapy and diagnosed with stomach cancer.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- The study consisted of experimental and control groups, both sexes, of patients diagnosed with gastric cancer.
| Arm | Type | Receives |
|---|---|---|
| Experimental Group | Experimental | Device: A device/tool called a stress ballParticipants who were given a stress ball |
| Control Group | No intervention | –Only the group being observed. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Between the ages of 18-80
- Those who agree to participate in the study
- Those without motor skill loss
- Patients diagnosed with stomach cancer
- Patients with hand-arm orientation skills
Key exclusion criteria (2 listed)
- Patients with loss of motor skills
- Patients who wish to withdraw from the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| A device/tool called a stress ballWe are investigating what effects stress balls have on the aforementioned areas/personal experiences. | Device | Experimental Group |
Primary outcome
Anxiety
Time frame: up to 6 months
Anxiety will be measured during chemotherapy.
1 secondary outcome
Nausea and fatigue
Time frame: up to 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Stomach Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 2/3
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Oesophageal Cancer, Gastric Cancer
Not yet recruitingPhase 1
GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis
Gastric Cancer (GC)
RecruitingPhase 3
A Study of Neoadjuvant-adjuvant Durvalumab and FLOT Chemotherapy Followed by Adjuvant Durvalumab in Chinese Patients With Resectable GC/GEJC.
Gastric, Esophagogastric Junction
Active, not recruitingEarly Phase 1
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
B-ALL, DLBCL
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yavuz Uren study director
Van Yüzüncü Yıl University Institute of Health Sciences
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing A device/tool called a stress ball in people with Stomach Cancer and Chemotherapy-induced Nausea and Vomiting, run by Yuzuncu Yil University at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Anxiety (time frame: up to 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.